Emosis announces the appointment of Dr. Jean Amiral as Chief Technology Officer
Strasbourg, France – June, 2017
Emosis, a medical device company specializing in cell-based hemostasis diagnostics, is proud to announce that Dr. Jean Amiral joins the Company as Chief Technology Officer (CTO), within a consultancy agreement with SH-Consulting.
Emosis SAS and LeukoDx Ltd awarded Eurostars grant to develop ClotSeek a screening hypercoagulation test for point of care and critical care
Strasbourg, France and Jerusalem, Israel, June 6th, 2017
The French diagnostic company Emosis SAS and the Israeli firm LeukoDx Ltd signed a cooperation agreement to set-up and validate an assay cartridge for real time in-vitro diagnostic (IVD) of blood coagulation. The project, which will be completed within 2 years, represents a total budget of 1.5 million euros and will be partially subsidised by the Eurostars grant.
Emosis Ltd, BioRap Technologies and Rambam MedTech Ltd. to collaborate on the development of novel hypercoagulation diagnostics kit
Tel-Aviv and Haifa, Israel March 2017
The diagnostics company Emosis Ltd., BioRap Technologies and Rambam MedTech Ltd, the technology transfer companies of the Rappaport Institute at the Technion - Israel Institute of Technology and Rambam Healthcare Campus, have entered into an exclusive license agreement to develop and commercialize hypercoagulation kit for several indications based on microparticles.